Mark Mannebach

Mark Mannebach is currently the Head of Regulatory Affairs & Pharmacovigilance at Harrow, Inc. and the Vice President of Regulatory Affairs at Celcuity, Inc. He previously held positions as the Vice President of Global Regulatory Affairs at Eiger BioPharmaceuticals, Inc., Exicure, Inc., Santen, Inc., and Mallinckrodt Pharmaceuticals.
Dr. Mannebach has a background in regulatory affairs and pharmacovigilance.
He obtained his undergraduate degree from Wayne State University, his graduate degree from the University of Detroit Mercy, and his doctorate from the University of Michigan.